HNRNPK and cancer: Notably, both hnRNP K and SETDB1 have been identified as bona fide oncogenes and are aberrantly overexpressed in a variety of human cancers including melanoma [67, 68], prostate carcinoma [69, 70] and lung carcinoma [71, 72].